PharmGen Science Market Cap

PharmGen Science has a market cap or net worth of 72.64 billion as of March 28, 2025. Its market cap has decreased by -30.95% in one year.

Market Cap

72.64B

Enterprise Value

73.17B

Revenue

171.29B

Ranking

n/a

PE Ratio

26.32

Stock Price

4,120.00

Market Cap Chart

Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 72.64B, an increase of 566.89%. That is a compound annual growth rate of 6.62%.

Market Cap History

Date	Market Cap	% Change
Mar 28, 2025	72.64B	-2.08%
Dec 30, 2024	74.18B	-33.39%
Dec 28, 2023	111.36B	5.58%
Dec 29, 2022	105.47B	-33.88%
Dec 30, 2021	159.51B	-3.78%
Dec 30, 2020	165.78B	123.51%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	38.03T
ALTEOGEN	18.79T
Yuhan	8,844.44B
SK Biopharmaceuticals	7,893.98B
HLB Co., Ltd.	7,500.72B
Sam Chun Dang Pharm.	3,930.51B
PharmaResearch	3,506.51B

Market Cap Rankings